Similarly, for AA + CRC versus control discrimination, the combination of SEPT9 and BMP3 methylation with age > 60 achieved a sensitivity of 74.0% and a specificity of 54.0% with an AUC of 0.715 (Figure 5B). This evidence concerns the gene SEPTIN9 and colorectal carcinoma.